Search results for: 'distributed data of service data'
- Related search terms
- Services 2.0: The New Business Frontier for Profitability
- data centers colocation market and base practices aware assessment
- data centers colocation market and base practices awar assessment
- data centers colocation market ad base practices adas assessment
- data solution market research methodology greater china
-
06 Nov 2025  |  Global  |  Market Research
Global Genetic Testing Industry, Forecast of 2025–2030
Population Screening Initiatives, Reproductive Health Demand, and Clinical Risk Stratification are Accelerating Growth in Genetic Testing, Enabled by Advancements in Sequencing Technologies and Data-Driven Interpretation
This research service offers a comprehensive analysis of the global genetic testing industry (specifically, germline genetic testing, which analyzes inherited genetic variations present in an individual from birth and can be passed to offspring). The industry growth is driven by a shift towards preventive care, rising maternal ages, increasing gove...
$4,950.00 -
15 Nov 2016  |  North America  |  Market Research
Healthcare 2020—Business Model Transformation Guidebook
Exploring New Models for Monetizing Services and Solutions
Healthcare as an industry is entering a phase of rapid transformation. Digitization of products, services, and commerce models are democratizing current healthcare systems and unlocking new values by displacing high-cost gatekeepers and previously inaccessible segments. Around 80% of the business models in 2025 will be driven by platform-based heal...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Sep 2016  |  North America  |  Market Research
Analysis of US Food Intolerance and Allergy Testing Market
Explore Potential Partners and Distribution Channels to Increase Market Position in the Direct-to-Consumer Pathway
The objective of this research is to understand the food intolerance and food allergy testing market in the United States. While allergy testing is common, food intolerance testing is provided by very few manufacturers, mostly as laboratory developed tests (LDTs) in the direct-to-consumer (DTC) pathway. The study includes key profiles of food intol...
$1,500.00
Special Price $1,125.00 save 25 %
-
29 Dec 2025  |  North America  |  Market Research
United States Clinical Laboratory Services Growth Opportunities, Forecast 2030
Fueled by Specialty Testing Expansion, Digital Workflow Innovation, and Value-Based Healthcare Demands
The clinical laboratory testing industry will continue to experience growth in testing volumes due to the aging of the US population, patient awareness of the benefits of laboratory testing, test cost reductions, the development of advanced and specialized tests for disease detection and management, the growing awareness of early detection and prev...
$4,950.00 -
18 Sep 2026  |  Global  |  Frost Radar
Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Laboratory information management systems (LIMS) have been used in life sciences since laboratories began digitizing sample tracking and data management in the 1970s. Modern LIMS solutions enhance efficiency by automating workflows, improving data accuracy, and enabling seamless integration and offer strong compliance, secure centralized data manag...
$4,950.00 -
09 Jul 2025  |  Global  |  Market Outlook
Global Clinical Diagnostics Outlook, 2025
Driven by Novel Biomarkers, Digital Services, and Automation, Industry is Accelerating Precision, Efficiency, and Early Disease Detection in Molecular Diagnostics and Point-of-care Testing (POCT)
The global clinical diagnostics market is poised for strong growth as stakeholders shift focus toward high-growth segments such as precision medicine, decentralized diagnostics, software-driven solutions, and product expansion. Companies continue to adopt LIMS and other digital platforms while emerging opportunities in the POCT sector further drive...
$4,950.00
Special Price $4,455.00 save 10 %
-
22 Jun 2026  |  Global  |  Market Research
Growth Opportunities, Global Life Sciences LIMS Market, Forecast to 2031
AI is Transforming Life Sciences LIMS by Automating Analysis, Enabling Predictive Insights, and Improving Efficiency and Decision-making
The global life sciences laboratory information management systems (LIMS) industry is forecast to grow from 2026 to 2031 at a CAGR of 8.5%, driven by the increasing need for laboratory automation, regulatory compliance, and cloud-based solutions. Leading players in the global life sciences LIMS market, including LabWare, Benchling, Clinisys, LabVan...
$4,950.00 -
30 Nov 2017  |  Europe  |  Market Research
Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021
Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth
Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanc...
$3,000.00
Special Price $2,250.00 save 25 %
-
27 Aug 2026  |  Global  |  Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, presenting opportunities for innovation. There has been a...
$4,950.00 -
05 Aug 2025  |  Global  |  Market Research
Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024–2030
Advances in Next-Generation Immunotherapies, AI, and Biomarker-Driven Personalization are Driving Transformational Growth
Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...
$4,950.00